These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 30229842)
21. [Role of ACE2-Ang (1-7)-Mas receptor axis in heart failure with preserved ejection fraction with hypertension]. Yu J; Wu Y; Zhang Y; Zhang L; Ma Q; Luo X Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 43(7):738-746. PubMed ID: 30124209 [TBL] [Abstract][Full Text] [Related]
22. Up-regulation of vascular and renal mitogen-activated protein kinases in hypertensive rats is normalized by inhibitors of the Na+/Mg2+ exchanger. Touyz RM; Yao G Clin Sci (Lond); 2003 Aug; 105(2):235-42. PubMed ID: 12725644 [TBL] [Abstract][Full Text] [Related]
23. Calcium/calmodulin-dependent kinase II inhibition in smooth muscle reduces angiotensin II-induced hypertension by controlling aortic remodeling and baroreceptor function. Prasad AM; Morgan DA; Nuno DW; Ketsawatsomkron P; Bair TB; Venema AN; Dibbern ME; Kutschke WJ; Weiss RM; Lamping KG; Chapleau MW; Sigmund CD; Rahmouni K; Grumbach IM J Am Heart Assoc; 2015 Jun; 4(6):e001949. PubMed ID: 26077587 [TBL] [Abstract][Full Text] [Related]
24. Candesartan ameliorates arsenic-induced hypertensive vascular remodeling by regularizing angiotensin II and TGF-beta signaling in rats. Khuman MW; Harikumar SK; Sadam A; Kesavan M; Susanth VS; Parida S; Singh KP; Sarkar SN Toxicology; 2016 Dec; 374():29-41. PubMed ID: 27889505 [TBL] [Abstract][Full Text] [Related]
27. Angiotensin II activates collagen I gene through a mechanism involving the MAP/ER kinase pathway. Tharaux PL; Chatziantoniou C; Fakhouri F; Dussaule JC Hypertension; 2000 Sep; 36(3):330-6. PubMed ID: 10988260 [TBL] [Abstract][Full Text] [Related]
28. Angiotensin (ang) 1-7 inhibits ang II-induced atrial fibrosis through regulating the interaction of proto-oncogene tyrosine-protein kinase Src (c-Src) and Src homology region 2 domain-containing phosphatase-1 (SHP-1)). Lu L; Cao L; Liu Y; Chen Y; Fan J; Yin Y Bioengineered; 2021 Dec; 12(2):10823-10836. PubMed ID: 34872449 [TBL] [Abstract][Full Text] [Related]
29. Resveratrol suppresses angiotensin II-induced Akt/protein kinase B and p70 S6 kinase phosphorylation and subsequent hypertrophy in rat aortic smooth muscle cells. Haider UG; Sorescu D; Griendling KK; Vollmar AM; Dirsch VM Mol Pharmacol; 2002 Oct; 62(4):772-7. PubMed ID: 12237323 [TBL] [Abstract][Full Text] [Related]
30. Renal denervation attenuates aldosterone expression and associated cardiovascular pathophysiology in angiotensin II-induced hypertension. Hong MN; Li XD; Chen DR; Ruan CC; Xu JZ; Chen J; Wu YJ; Ma Y; Zhu DL; Gao PJ Oncotarget; 2016 Oct; 7(42):67828-67840. PubMed ID: 27661131 [TBL] [Abstract][Full Text] [Related]
31. Involvement of Rho-kinase pathway for angiotensin II-induced plasminogen activator inhibitor-1 gene expression and cardiovascular remodeling in hypertensive rats. Kobayashi N; Nakano S; Mita S; Kobayashi T; Honda T; Tsubokou Y; Matsuoka H J Pharmacol Exp Ther; 2002 May; 301(2):459-66. PubMed ID: 11961044 [TBL] [Abstract][Full Text] [Related]
32. The mechanisms of Ang II-induced hypertensive vascular remodeling under suppression of CD68 in macrophages. Zhao ZG; Wang HF; Wang YW; Li J; Li YX; Xin H; Liu JJ; Guan XM Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):6093-6099. PubMed ID: 30280796 [TBL] [Abstract][Full Text] [Related]
33. Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress. Briones AM; Rodríguez-Criado N; Hernanz R; García-Redondo AB; Rodrigues-Díez RR; Alonso MJ; Egido J; Ruiz-Ortega M; Salaices M Hypertension; 2009 Jul; 54(1):142-9. PubMed ID: 19451411 [TBL] [Abstract][Full Text] [Related]
34. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy. Neves MF; Amiri F; Virdis A; Diep QN; Schiffrin EL; Can J Physiol Pharmacol; 2005 Nov; 83(11):999-1006. PubMed ID: 16391708 [TBL] [Abstract][Full Text] [Related]
35. Effect of oxymatrine, the active component from Radix Sophorae flavescentis (Kushen), on ventricular remodeling in spontaneously hypertensive rats. Huang XY; Chen CX Phytomedicine; 2013 Feb; 20(3-4):202-12. PubMed ID: 23211799 [TBL] [Abstract][Full Text] [Related]
36. Effects of p38 MAPK Inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production. Bao W; Behm DJ; Nerurkar SS; Ao Z; Bentley R; Mirabile RC; Johns DG; Woods TN; Doe CP; Coatney RW; Ohlstein JF; Douglas SA; Willette RN; Yue TL J Cardiovasc Pharmacol; 2007 Jun; 49(6):362-8. PubMed ID: 17577100 [TBL] [Abstract][Full Text] [Related]
37. Angiotensin II-Induced vascular remodeling and hypertension involves cathepsin L/V- MEK/ERK mediated mechanism. Lu Y; Sun X; Peng L; Jiang W; Li W; Yuan H; Cai J Int J Cardiol; 2020 Jan; 298():98-106. PubMed ID: 31668507 [TBL] [Abstract][Full Text] [Related]
38. 6β-Hydroxytestosterone, a metabolite of testosterone generated by CYP1B1, contributes to vascular changes in angiotensin II-induced hypertension in male mice. Pingili AK; Jennings BL; Mukherjee K; Akroush W; Gonzalez FJ; Malik KU Biol Sex Differ; 2020 Jan; 11(1):4. PubMed ID: 31948482 [TBL] [Abstract][Full Text] [Related]
39. Orphan Nuclear Receptor Nur77 Inhibits Angiotensin II-Induced Vascular Remodeling via Downregulation of β-Catenin. Cui M; Cai Z; Chu S; Sun Z; Wang X; Hu L; Yi J; Shen L; He B Hypertension; 2016 Jan; 67(1):153-62. PubMed ID: 26597820 [TBL] [Abstract][Full Text] [Related]
40. Early treatment with losartan effectively ameliorates hypertension and improves vascular remodeling and function in a prehypertensive rat model. He DH; Lin JX; Zhang LM; Xu CS; Xie Q Life Sci; 2017 Mar; 173():20-27. PubMed ID: 28161159 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]